Impact of Anesthesia, Positive Pressure Ventilation and Modality of Imaging on the Echocardiographic Assessment of the Severity of Aortic Regurgitation
Launched by UNIVERSITY OF LIEGE · Feb 14, 2025
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different ways of imaging the heart can affect the assessment of aortic regurgitation, which is a condition where the heart's aortic valve doesn't close properly, causing blood to flow back into the heart. Researchers are comparing two types of echocardiograms (heart ultrasounds): one done on the chest (trans-thoracic echo or TTE) before patients receive anesthesia, and another done through the esophagus (trans-esophageal echo or TEE) after anesthesia has started. The goal is to understand how anesthesia and breathing support during surgery might change the way doctors evaluate the severity of aortic regurgitation.
To be eligible for this study, participants need to have a known degree of aortic regurgitation and be scheduled for cardiac surgery where a TEE will be performed. Some people may not qualify if they have certain heart conditions or are in a critical state before surgery. If you decide to participate, you will undergo both types of echocardiograms, allowing researchers to gather important information that could help improve heart assessments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Known aortic regurgitation of any grade
- • Scheduled for a cardiac surgery procedure during which a trans-esophageal echo is planned.
- Exclusion Criteria:
- • Non sinus rhythm
- • Mitral regurgitation more than mild.
- • Pre-operative critical state (according to the definition of the EuroSCORE II)
- • Presence of a prosthetic aortic valve
- • Contra-indication to trans-esophageal echo
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liège, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported